In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes with  -cyclodextrin is not inhibited by high-density lipoproteins.

Slides:



Advertisements
Similar presentations
Topical Bioequivalence Update Robert Lionberger, Ph.D. Office of Generic Drugs.
Advertisements

H3 Absorption of digested foods
Assessment Statements H.3.1 Draw and label a diagram showing a transverse section of the ileum as seen under a light microscope. H.3.2 Explain the structural.
© 2011 Pearson Education, Inc. Key Concepts Plasma membranes are made up of selectively permeable bilayers of phospholipids. Phospholipids are amphipathic.
STUDY OF THE EFFECT OF THE XCIPIENT CROSSCARMELOSE ON METFORMIN INTESTINAL PERMEABILITY BY AN IN SITU INTESTINAL PERFUSION MODEL IN RATS Sodium chloride.
Chapters 9 & 10: V itamins. © 2010 Pearson Education, Inc. Vitamins  Tasteless, organic compounds  Required in small amounts  Functions Regulate metabolism.
Aim of work The main objective of this investigation was to optimize the formulation of chitosan beads with Ketorolac tromethamine to minimize the gastrointestinal.
Pharmacokinetics & Pharmacodynamics of Controlled Release Systems Presented By: Govardhan.P Dept. of pharmaceutics, University College of Pharmaceutical.
PHARMACOLOGY CH. 5 Pharmacokinetics. Pharmacokinetics explained… How the body handles the drugs that are administered to it, how the drugs are changed.
Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.
Enhanced molecular delivery
Plant Sterols Roles in Margarines Pennington Biomedical Research Center Division of Education Heli J. Roy PhD Shanna Lundy, BS Phillip Brantley, PhD, Director.
GASTON A. TUMUHIMBISE, PhD DEPARTMENT OF FOOD TECHNOLOGY AND NUTRITION
Quality by Design Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants.
Wilnerys Colberg Hernández
PHARMACEUTICS- IV (PHT 414 ) Dr. Shahid Jamil SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L /9/2015 Factors Affecting Drug Absorption (Dosage.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
COMPARATIVE IN VITRO EVALUATION OF GENERIC CIPROFLOXACIN HYDROCHLORIDE TABLETS IN KENYA BY DANIEL MINYETO U59/81286/2012 Department of Pharmaceutical Chemistry.
Mayfield Publishing Company Essential Nutrients  Nutrients the body cannot produce in sufficient quantity for its needs – proteins – fats – carbohydrates.
Improving solubility and cellular absorption of Paclitaxel with solid lipid nanoparticles and cyclodextrin Jong-Suep Baek, Jae-Woo So, Ji-Sook Hwang, Cheong-Weon.
From last time… Pressure = force/area Two major pressures in plants. 1. The positive pressure (turgor) inside living cells and that’s required for cell.
Bioavailability Dr Mohammad Issa.
Effect of processing on in vitro bioaccessibility of phenolics, flavonoids and antioxidant activity of vegetables with/without yoghurt Assoc. Prof. Dr.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
1 Humic Substances Seminar VII March , Northeastern University Boston, MA, USA Physical and Chemical Kinetics in Humic Dispersions Martina.
1 The Biopharmaceutical Classification System (BCS) Dr Mohammad Issa.
Biopharmaceutics refers to the relationship of the:
A Parmaceutical Study on Felodipine(Preparation and evaluation of Felodipine Therapeutic Transdermal system) Ahmed Abd El-Bary, Mohamed M. Nafady, Mahmoud.
LECTURE 4 FACILITATED DIFFUSION
Tetraterpenoid البرفسور الدكتور طلال ابورجيع. Tetraterpenoids CAROTENOIDS Among this important group, the numerous compounds consist of C40 chains with.
Lipophilicity & Permeability 김연수. Chapter 5. Lipophilicity.
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
The Biopharmaceutical Classification System (BCS)
Introduction What is a Biowaiver?
Pharmacology Department
Bioavailability of Dietary Supplements: Key Issues in Defining the Research Agenda Impact of Formulation on Bioavailability? Discussion Leader: Stephen.
김소연 Permeability OverviewPermeability FundamentalsPermeability EffectPermeability Structure Modification StrategiesProblem.
Lecture 7 PHARMACOKINETICS
PHYSIOLOGY 1 LECTURE 10 DIFFUSION Simple, Facilitated, Active.
Intestinal Villi. Absorption of Fat Glycerol + Short Chain Fatty Acids  Intestinal Cells  Capillaries  Liver  Bloodstream.
In vitro - In vivo Correlation
Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate Ref.: European Journal of Pharmaceutics.
CELECOXIB (BCS CLASS II MODEL DRUG) SOLUBILITY ENHANCEMENT BY CYCLODEXTRIN COMPLEXATION. Abhishek Juluri 1,Carmen Popescu 2, Prashanth Manda 1, Leon Zhou.
Inclusion Complexes of Piroxicam with B-Cyclodextrin Derivatives
Nutrients To survive, the human body needs the nutrients found in food. Nutrients are classified into six groups.
Chapter 18.2a The Digestive System.
Faisal W., O'Driscoll C. M. and Griffin B. T.1
The Biopharmaceutical Classification System (BCS)
Pharmacology I BMS 242 Lecture II (Continued)
Drugs for Lipid Disorders
OLIVE OIL 1.
Introduction What is a Biowaiver?
To survive, the human body needs the nutrients found in food.
3.4 Diffusion and Osmosis KEY CONCEPT Materials move across membranes because of concentration differences.
Medicinal chemistry Third stage Lecture 1
Waleed Faisal, Caitriona O'Driscoll, Brendan Griffin1
Cocoa extract inhibits in vitro α-glucosidase activity:
Investigations of the mechanisms of absorption of lycopene from the gastro-intestinal tract of the rat. Faisal W., O'Driscoll C. M. and Griffin B. T.1.
Pharmacology I BMS 242 Lecture II (Continued)
Scientific rationale for EU regulatory expectations concerning product composition in case of Class-I and Class-III medicinal products Dr Ridha BELAIBA.
Introduction to Pharmacology
The Biopharmaceutical Classification System (BCS)
Absorption of Nutrients
FOODstars Fortified Foods
3.4 Diffusion and Osmosis KEY CONCEPT Materials move across membranes because of concentration differences.
Therapeutic Drug Monitoring chapter 1 part 1
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
2 types of passive transport
3.4 Diffusion and Osmosis KEY CONCEPT Materials move across membranes because of concentration differences.
Dr. Basavaraj K. Nanjwade M. Pharm, PhD. Department of Pharmaceutics
Presentation transcript:

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes with  -cyclodextrin is not inhibited by high-density lipoproteins Elisabet Fernández-García, Irene Carvajal-Lérida, Francisco Rincón, José J. Ríos and Antonio Pérez-Gálvez* Food Biotechnology Department Instituto de la Grasa (CSIC) Av. Padre García Tejero 4, Sevilla (SPAIN)

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… SIGNIFICANCE OF BIOAVAILABILITY STUDIES Interest in the screening of bioavailability has increased for different reasons 1.Existence of undernourished population 2.Epidemiological studies have associated between consumption of fruit and vegetables to a lower risk of developing degenerative diseases 3.Development of food products with added nutritional value 4.Food legislation concerning functional foods

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… A MULTIFACTORIAL SYSTEM EFFECTS CAROTENOID ASSIMILATION Carotenoids are fat soluble compounds 1.Liberation from food matrix 2.Incorporation to mixed micelles 3.Absorption by epithelial cells through simple/facilitated diffusion mechanisms Absorption efficiency is relatively low from fruits and vegetables 1.Fiber, kind and amount of fat, interaction among carotenoids 2.Increase of absorption efficiency from processed fruits and vegetables (homogenization and thermal processing)

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… Responders group non-Responders group INTER-INDIVIDUAL VARIABILITY AND THE NON-RESPONDER CONCEPT Comparison of the in vivo lutein absorption efficiency: non-responder versus lutein-responders group

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… AIM OF THE STUDY Estimation of the bioaccessibility of dietary carotenoids reached when they are delivered as inclusion complexes 1.Dietary carotenoids (  -carotene, lutein and lycopene) were formulated as micellar solutions (control) or inclusion complexes with  -cyclodextrin 2.BBMVs preparations were used as the in vitro model to assay carotenoid uptake from both carotenoid formulations (micellar solution or carotenoid-CyDIC) at three concentration levels 3.Comparison of absorption efficiency under inhibition conditions of membrane protein transporters (BBMVs pre- incubated with HDLs)

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotenoid absorption efficiency in function of the concentration and delivering method Assimilation of  -carotene micellar inclusion complex 1.Saturation versus linear trend 2.Increase of efficiency at 2.5  M

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotenoid absorption efficiency in function of the concentration and delivering method Assimilation of lycopene micellar inclusion complex 1.Saturation versus linear trend 2.Increase of efficiency at 1.0  M

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotenoid absorption efficiency in function of the concentration and delivering method Assimilation of lutein micellar inclusion complex 1.Saturation versus linear trend 2.Increase of efficiency at 2.5  M 3.A lower absorption efficiency was observed versus carotenes

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes…  -carotene luteinlycopene Concentration Donor solution type Inhibition RESULTS Primary effects of the factors concentration, donor solution type and inhibition

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… SUMMARY Factors: concentration and donor solution type 1.Association between concentration and assimilation mechanism 2.Structural features (polarity) or different affinity of transporters may explain the absorption efficiency data of carotenes and lutein 3.Significant increase on efficiency of the assimilation is reached when carotenoids were delivered as inclusion complex with CyD

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Does delivery of carotenoids as inclusion complex mean an increase on absorption efficiency? Absorption rate in pmol/(mg protein x min) C. E.C. I. C.  -carotene C. E.C. I. C. lutein C. E.C. I. C. lycopene 0.5  M 1.0  M 2.5  M

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… SUMMARY Factors: concentration and donor solution type 1.At the lowest concentration the carotenoids from micellar solutions were more efficiently assimilated 2.At 1.0  M a heterogeneous behavior was observed 3.Only at the highest concentration, carotenoids from inclusion complex solutions were more efficiently assimilated in comparison with the carotenoid micellar solutions at that concentration (  -Car: 51%; Lut: 185%; Lyc: 128%). What absorption mechanism does apply for inclusion complexes?

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Two-stage mechanism for carotenoid assimilation from inclusion complex solutions: release and absorption Lutein inclusion complex at the donor solution Lysate of BBMVs after assimilation procedure with lutein inclusion complex at the donor solution

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… K complexation Assimilation: Passive or facilitated diffusion + De-complexation RESULTS Solubility of carotenoids is a rate-limiting step of absorption. Dissolution kinetics of the complex is enhanced at high concentrations and depends on binding constant of the host- guest complex

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotenoid absorption efficiency in function of the concentration and delivering method with inhibitor Assimilation of  -carotene micellar inclusion complex 1.Decrease of 50% (mean value) 2.Saturation versus linear trend 3.Increase of efficiency at 0.5  M

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotenoid absorption efficiency in function of the concentration and delivering method with inhibitor Assimilation of lycopene micellar inclusion complex 1.Decrease of 40% (mean value) 2.Saturation versus linear trend 3.Increase of efficiency at 0.5  M

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotenoid absorption efficiency in function of the concentration and delivering method with inhibitor Assimilation of lutein micellar inclusion complex 1.Decrease of 70% (mean value) 2.Saturation versus linear trend 3.Increase of efficiency at 0.5  M

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes…  -carotene luteinlycopene Concentration Donor solution type Inhibition RESULTS Primary effects of the factors concentration, donor solution type and inhibition

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… SUMMARY Factors: concentration, donor solution type and inhibition 1.Assimilation of carotenoids from micellar solutions is significantly inhibited with the use of HDLs 2.Significant decrease of the assimilation level, (70% drop for lutein), although it did not reached 100%. Co-existence of simple diffusion mechanism and work of transporters not totally blocked under the established experimental conditions 3.Carotenes were more efficiently absorbed than lutein even under inhibition conditions. They probably take help of different protein transporters

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… SUMMARY Factors: concentration, donor solution type and inhibition 4.Carotenoid-CyDIC were more efficiently absorbed than the carotenoid micellar solutions under inhibition conditions. How did the factor inhibition affect the carotenoid assimilation from CyDIC?

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotene-CyDIC absorption efficiency in function of the inhibition factor Assimilation of  -carotene-CyDIC no inhibition inhibition 1.Increase of efficiency from 0.5  M under inhibited transport conditions 2.Increase of 86% at 1.0  M

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotene-CyDIC absorption efficiency in function of the inhibition factor Assimilation of lycopene-CyDIC no inhibition inhibition 1.Increase of efficiency from 0.5  M under inhibited transport conditions 2.Increase of 165% at 1.0  M

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotene-CyDIC absorption efficiency in function of the inhibition factor

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the carotene-CyDIC absorption efficiency in function of the inhibition factor

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… RESULTS Comparison of the lutein absorption efficiency in function of the inhibition factor Assimilation of lutein at 1.0  M micellar inclusion complex 1.70% drop of micellar lutein under inhibited transport conditions 2.28% drop of lutein-CyDIC under inhibited transport conditions

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… SUMMARY Comparison of the carotenoid-CyDIC absorption efficiency in function of the inhibition factor 1.A different effect of HDLs was observed for the assimilation efficiency of carotene-CyDICs or lutein-CyDICs 2.Process of competition between HDLs and lutein-CyDIC may not be efficient enough in comparison with the same process for carotene-CyDIC 3.Inhibition promoted by HDLs affects specific protein transporters

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… SUMMARY Comparison of the in vivo lutein absorption efficiency: non-responder versus lutein-responders group non-Responders group Lutein-responders group

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… CONCLUSIONS Factors: concentration, donor solution type and inhibition 1.First, inter-individual differences on carotenoid assimilation efficiency should be evaluated, as they are a direct consequence of facilitated diffusion mechanism and expression/location of transporters. Interaction with drugs 2.New strategies to increase carotenoid assimilation to develop food formulae. Interaction with lipoprotein/apoprotein components

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… CONCLUSIONS Factors: concentration, donor solution type and inhibition 3.Data point to the existence of different affinity of transporters and even different transporters for carotenes and the xanthophyll lutein. Non-/low-responder effect 4.Bringing pharmaceutical concepts to food technology and nutrition will help to consolidate functional food

In vitro intestinal absorption of carotenoids delivered as molecular inclusion complexes… ACKNOWLEGMENTS Financial support from Spanish Government (projects AGL ; AGR-03025) Scientific and organizing committees of the 6 th International Congress on Pigments in Food - Budapest Dr. Antonio Pérez-Gálvez; Food Biotechnology Department Instituto de la Grasa (CSIC) Av. Padre García Tejero 4, Sevilla (SPAIN) THANKS FOR YOUR ATTENTION!